Indian biotechnology giant Bharat Biotech said on Tuesday (Aug 27) that its oral cholera vaccine Hillchol cleared a late-stage trial. Bharat Biotech said that India's drug regulator approved the vaccine, adding, it was now planning for a global launch.

India's Bharat Biotech plans global launch for its oral cholera vaccine Hillchol

Bharat Biotech nasal vaccine price: Bharat Biotech International Limited Tuesday declared that its anti-Covid nasal spray vaccine is now available on the CoWIN portal.

Bharat Biotech nasal vaccine price and launch date revealed! Know how does a nasal vaccine work

An intranasal Covid vaccine developed by Bharat Biotech will be available for the public on the CoWIN website from Friday as India gears up surveillance, and prepares to counter a possible COVID-19 wave.

India: Bharat Biotech’s nasal Covid vaccine to be available as booster dose on CoWIN app now

Indian biotech firm Bharat Biotech on Saturday claimed that its Covid vaccine, Covaxin, offered long-term protection against severe Covid disease when used as a booster dose during the clinical trial.

Covaxin booster offers long-term protection against severe Covid infection: Bharat Biotech

Bharat Biotech, the maker of India's COVID-19 vaccine Covaxin, said on Tuesday that it was studying whether the vaccine would work against Omicron variant. The development follows warning from Moderna CEO about existing vaccines potentially being less effective against Omicron which is feared to be more transmissible and dangerous than previous coronavirus variants.

Omicron threat: Covaxin maker Bharat Biotech studying if vaccine works against variant

From November 22, the UK government plans to add India's Covaxin to a list of COVID-19 vaccines approved for international travellers. Therefore, those inoculated with the Bharat Biotech vaccine will not need to isolate themselves after arriving in England.

India's Covaxin to be added to UK approved list from November 22

US company Ocugen announced Friday that it had asked authorities for emergency use authorisation for COVID-19 vaccine Covaxin, which was developed in India, for ages 2 to 18.

Approval sought in US for India-made Covaxin's use on those aged 2 to 18

The Technical Advisory Group (TAG), an independent advisory council of the World Health Organization (WHO), has recommended that Bharat Biotech's COVID-19 vaccine Covaxin be given Emergency Use Listing (EUL) designation.

Bharat Biotech's Covid vaccine Covaxin gets emergency use listing from WHO panel

As thousands of Indians who used to work or live abroad are stuck at home country due to lack of global recognition for Covaxin jab which they had taken, the WHO has again delayed approval for the made-in-India Covid shot.

Delayed again: WHO seeks more 'clarifications' on made-in-India Covid shot Covaxin

The World Health Organization (WHO) seeks 'additional clarifications' from Bharat Biotech for Covaxin to conduct a final 'risk-benefit assessment' for emergency use listing of the vaccine.

No WHO approval for Bharat Biotech' Covaxin as panel wants more details

As India on Thursday achieved the milestone of administering 1billion COVID-19 vaccine doses so far, Chairman and Managing Director of Bharat Biotech Dr Krishna Ella lauded the government's system for this achievement.

One billion COVID-19 vaccine doses: Bharat Biotech chairman lauds govt; terms it significant feat

The subject expert committee of India's drug regulator is all set to take a call on Bharat Biotech’s pediatric COVID vaccine. Bharat biotech, which completed its phase-ii and iii trials of Covaxin's pediatric jab has submitted the data to the central drugs standard control organization for its verification and subsequent approval.

India's drug regulator all set to take call on Bharat Biotech’s pediatric COVID vaccine

Bharat Biotech has terminated a memorandum of understanding to sell its COVID-19 vaccine Covaxin to Brazil's Precisa Medicamentos, the Indian company said on Friday without disclosing the reason.

Bharat Biotech terminates Covaxin deal with Brazil after graft allegations

Ocugen Inc., Bharat Biotech's partner for the USA and Canada for COVID-19 vaccine Covaxin has initiated a rolling submission to Health Canada for the jab, the US company said in a regulatory filing.

Bharat Biotech's partner seeks approval for India-made Covaxin in Canada

Bharat Biotech said that it has concluded the final analysis for its COVID-19 vaccine Covaxin as part of phase-3 clinical trials. The Hyderabad-based pharma company claimed that its indigenous jab demonstrates an overall efficacy of 77.8% against symptomatic infection.

Bharat Biotech announces Covaxin's efficacy rate after final stage trials

Brazilian President Jair Bolsonaro fired a health official on Wednesday after he reportedly asked for a bribe in a coronavirus vaccine deal, the latest graft accusation to rock the government and spark fresh calls for the president's impeachment.

As calls grow for his impeachment, Bolsonaro fires official over graft claims

India's home-made shot Covaxin is at the centre of a storm in Brazil. Federal prosecutors in Brazil suspect corruption in the way Bharat Biotech's representative reached an agreement with the government. Palki Sharma tells you more.

Gravitas: Covaxin at the centre of a storm in Brazil

Brazilian federal prosecutors have opened an investigation into a contract worth 1.6 billion reais ($320 million) for 20 million doses of a COVID-19 vaccine made by India's Bharat Biotech, according to a document seen by Reuters on Tuesday.

Brazil prosecutors probe price, intermediary on Bharat Biotech vaccine deal

Bringing the Indian Covid vaccine Covaxin a step closer to World Health Organization's approval, the pre-submission meeting will be taking place on June 23. WHO documents show the Expression of Interest (EOI) has been accepted by the Geneva-based body.

COVID-19: Bharat Biotech's pre-submission meeting for Covaxin's WHO approval on June 23

A key meeting between Bharat Biotech's Executive Director Dr V Krishna Mohan and other officials of the Hyderabad-based pharma major and senior officials of the Ministry of External Affairs, Ministry of Health, Department of Biotechnology took place on Monday as India pushed for early approval of Covaxin by the World Health Organization (WHO).

Ahead of WHO-Bharat Biotech meet on Covaxin, key stakeholders come together

Hyderabad-based Bharat Biotech has summitted application to the World Health Organization for Emergency Use Listing (EUL) of its Covid vaccine Covaxin, becoming the second India-made vaccine to apply at the global body for authorisation.

Bharat Biotech applies for WHO nod for Covaxin; pre-submission meeting soon

Indian Covid vaccine maker Bharat Biotech's Joint Managing Director Suchitra Ella expressed confidence over meeting commitments that have been made to Government of India.

Exclusive: Bharat Biotech's Joint MD Suchitra Ella confident on Covid vaccine production commitments

Suchitra Ella, joint managing director of Bharat Biotech has expressed confidence on meeting commitments that have been "made to govt of India", with the company aiming to produce 1 billion COVID vaccine COVAXIN doses involving facilities in Hyderabad, Bangalore, and Ankleshwar. Ella co-founded the company along with Dr Krishna M Ella and its COVID vaccine along with Covishield and sputnik are the only 3 vaccines allowed in India.

Bharat Biotech's Suchitra Ella confident on vaccine production commitments

bharat-biotech

Bharat Biotech, News on Bharat Biotech, stories on Bharat Biotech, articles on Bharat Biotech, Bharat Biotech stories at Wion, Bharat Biotech news, Bharat Biotech latest news

bharat biotech

India's Bharat Biotech plans global launch for its oral cholera vaccine Hillchol

Bharat Biotech nasal vaccine price and launch date revealed! Know how does a nasal vaccine work

India: Bharat Biotech’s nasal Covid vaccine to be available as booster dose on CoWIN app now

Covaxin booster offers long-term protection against severe Covid infection: Bharat Biotech

Omicron threat: Covaxin maker Bharat Biotech studying if vaccine works against variant

India's Covaxin to be added to UK approved list from November 22

Approval sought in US for India-made Covaxin's use on those aged 2 to 18

Bharat Biotech's Covid vaccine Covaxin gets emergency use listing from WHO panel

Delayed again: WHO seeks more 'clarifications' on made-in-India Covid shot Covaxin

No WHO approval for Bharat Biotech' Covaxin as panel wants more details

No WHO approval for Bharat Biotech' Covaxin as panel wants more details

One billion COVID-19 vaccine doses: Bharat Biotech chairman lauds govt; terms it significant feat

India's drug regulator all set to take call on Bharat Biotech’s pediatric COVID vaccine

Bharat Biotech terminates Covaxin deal with Brazil after graft allegations

Bharat Biotech's partner seeks approval for India-made Covaxin in Canada

Bharat Biotech announces Covaxin's efficacy rate after final stage trials

As calls grow for his impeachment, Bolsonaro fires official over graft claims

Gravitas: Covaxin at the centre of a storm in Brazil

Brazil prosecutors probe price, intermediary on Bharat Biotech vaccine deal

COVID-19: Bharat Biotech's pre-submission meeting for Covaxin's WHO approval on June 23

Ahead of WHO-Bharat Biotech meet on Covaxin, key stakeholders come together

Bharat Biotech applies for WHO nod for Covaxin; pre-submission meeting soon

Exclusive: Bharat Biotech's Joint MD Suchitra Ella confident on Covid vaccine production commitments

Bharat Biotech's Suchitra Ella confident on vaccine production commitments